Nenad Vasic1, Nadine D Wolf1, Georg Grön1, Zrinka Sosic-Vasic1, Bernhard J Connemann1, Fabio Sambataro1, Anna von Strombeck1, Dirk Lang1, Stefanie Otte1, Manuela Dudek1, Robert C Wolf1. 1. Department of Forensic Psychiatry and Psychotherapy, University of Ulm, Germany (Vasic, Dudeck, Otte); Department of Psychiatry and Psychotherapy III, University of Ulm, Germany ( Vasic, Grön, Sosic-Vasic, Connemann, Von Strombeck, Lang); Department of Psychiatry, Psychotherapy and Psychosomatics, Saarland University, Homburg, Germany (N. Wolf, R. Wolf); Brain Center for Motor and Social Cognition@UniPR, Istituto Italiano di Tecnologia, Parma, Italy (Sambataro); Clinic for Psychosomatic Medicine and Psychotherapy, University of Ulm, Germany (Lang).
Abstract
BACKGROUND: Abnormal regional cerebral blood flow (rCBF) and grey matter volume have been frequently reported in patients with major depressive disorder (MDD). However, it is unclear to what extent structural and functional change co-occurs in patients with MDD and whether markers of neural activity, such as rCBF, can be predicted by structural change. METHODS: Using MRI, we investigated resting-state rCBF and brain structure in patients with MDD and healthy controls between July 2008 and January 2013. We acquired perfusion images obtained with continuous arterial spin labelling, used voxel-based morphometry to assess grey matter volume and integrated biological parametric mapping analyses to investigate the impact of brain atrophy on rCBF. RESULTS: We included 43 patients and 29 controls in our study. Frontotemporal grey matter volume was reduced in patients compared with controls. In patients, rCBF was reduced in the anterior cingulate and bilateral parahippocampal areas and increased in frontoparietal and striatal regions. These abnormalities were confirmed by analyses with brain volume as a covariate. In patients with MDD there were significant negative correlations between the extent of depressive symptoms and bilateral parahippocampal rCBF. We found a positive correlation between depressive symptoms and rCBF for right middle frontal cortical blood flow. LIMITATIONS: Medication use in patients has to be considered as a limitation of our study. CONCLUSION: Our data suggest that while changes of cerebral blood flow and brain volume co-occur in patients with MDD, structural change is not sufficient to explain altered neural activity in patients at rest. Abnormal brain structure and function in patients with MDD appear to reflect distinct levels of neuropathology.
BACKGROUND: Abnormal regional cerebral blood flow (rCBF) and grey matter volume have been frequently reported in patients with major depressive disorder (MDD). However, it is unclear to what extent structural and functional change co-occurs in patients with MDD and whether markers of neural activity, such as rCBF, can be predicted by structural change. METHODS: Using MRI, we investigated resting-state rCBF and brain structure in patients with MDD and healthy controls between July 2008 and January 2013. We acquired perfusion images obtained with continuous arterial spin labelling, used voxel-based morphometry to assess grey matter volume and integrated biological parametric mapping analyses to investigate the impact of brain atrophy on rCBF. RESULTS: We included 43 patients and 29 controls in our study. Frontotemporal grey matter volume was reduced in patients compared with controls. In patients, rCBF was reduced in the anterior cingulate and bilateral parahippocampal areas and increased in frontoparietal and striatal regions. These abnormalities were confirmed by analyses with brain volume as a covariate. In patients with MDD there were significant negative correlations between the extent of depressive symptoms and bilateral parahippocampal rCBF. We found a positive correlation between depressive symptoms and rCBF for right middle frontal cortical blood flow. LIMITATIONS: Medication use in patients has to be considered as a limitation of our study. CONCLUSION: Our data suggest that while changes of cerebral blood flow and brain volume co-occur in patients with MDD, structural change is not sufficient to explain altered neural activity in patients at rest. Abnormal brain structure and function in patients with MDD appear to reflect distinct levels of neuropathology.
Authors: Rebecca Kerestes; Zubin Bhagwagar; Pradeep J Nathan; Shashwath A Meda; Cecile D Ladouceur; Kathleen Maloney; David Matuskey; Barbara Ruf; Aybala Saricicek; Fei Wang; Godfrey D Pearlson; Mary L Phillips; Hilary P Blumberg Journal: Psychiatry Res Date: 2012-05-16 Impact factor: 3.222
Authors: Ming-Ying Du; Qi-Zhu Wu; Qiang Yue; Jun Li; Yi Liao; Wei-Hong Kuang; Xiao-Qi Huang; Raymond C K Chan; Andrea Mechelli; Qi-Yong Gong Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2011-10-07 Impact factor: 5.067
Authors: Sean J Colloby; Michael J Firbank; Jiabao He; Alan J Thomas; Akshya Vasudev; Steve W Parry; John T O'Brien Journal: Br J Psychiatry Date: 2011-12-22 Impact factor: 9.319
Authors: Wenjing Wei; Helmet T Karim; Chemin Lin; Akiko Mizuno; Carmen Andreescu; Jordan F Karp; Charles F Reynolds; Howard J Aizenstein Journal: J Clin Psychiatry Date: 2018-10-23 Impact factor: 4.384
Authors: Margarita Abi Zeid Daou; Brian D Boyd; Manus J Donahue; Kimberly Albert; Warren D Taylor Journal: J Psychiatr Res Date: 2017-11-11 Impact factor: 4.791
Authors: Ashish K Sahib; Joana R A Loureiro; Megha M Vasavada; Antoni Kubicki; Shantanu H Joshi; Kai Wang; Roger P Woods; Eliza Congdon; Danny J J Wang; Michael L Boucher; Randall Espinoza; Katherine L Narr Journal: Eur Neuropsychopharmacol Date: 2020-02-12 Impact factor: 5.415